BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
PTPN11 |
Q06124
|
protein tyrosine phosphatase non-receptor type 11
|
|
1.00 |
0.385 |
0.923 |
BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
RAF1 |
P04049
|
Raf-1 proto-oncogene, serine/threonine kinase
|
Kinase
|
0.85 |
0.418 |
0.885 |
RAD51 |
Q06609
|
RAD51 recombinase
|
|
2.7E-02 |
0.447 |
0.846 |
ERCC4 |
Q92889
|
ERCC excision repair 4, endonuclease catalytic subunit
|
Enzyme
|
1.4E-12 |
0.468 |
0.846 |
FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
DHCR7 |
Q9UBM7
|
7-dehydrocholesterol reductase
|
Enzyme
|
3.9E-13 |
0.500 |
0.846 |
PALB2 |
Q86YC2
|
partner and localizer of BRCA2
|
|
3.0E-19 |
0.485 |
0.769 |
RECQL4 |
O94761
|
RecQ like helicase 4
|
Enzyme
|
3.3E-35 |
0.496 |
0.808 |
CCND2 |
P30279
|
cyclin D2
|
Enzyme modulator
|
0.99 |
0.477 |
0.808 |
FANCC |
Q00597
|
FA complementation group C
|
|
2.8E-13 |
0.507 |
0.808 |
FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
RAI1 |
Q7Z5J4
|
retinoic acid induced 1
|
Transcription factor
|
1.00 |
0.545 |
0.731 |
FLII |
Q13045
|
FLII actin remodeling protein
|
|
5.5E-12 |
0.520 |
0.808 |
BRIP1 |
Q9BX63
|
BRCA1 interacting protein C-terminal helicase 1
|
Enzyme
|
6.2E-17 |
0.507 |
0.731 |
XRCC2 |
O43543
|
X-ray repair cross complementing 2
|
|
4.0E-07 |
0.512 |
0.731 |
AKT3 |
Q9Y243
|
AKT serine/threonine kinase 3
|
Kinase
|
1.00 |
0.512 |
0.808 |
RAD51C |
O43502
|
RAD51 paralog C
|
|
6.2E-14 |
0.533 |
0.692 |
DEAF1 |
O75398
|
DEAF1 transcription factor
|
|
3.4E-04 |
0.575 |
0.615 |
IQSEC2 |
Q5JU85
|
IQ motif and Sec7 domain ArfGEF 2
|
|
1.00 |
0.573 |
0.577 |
FANCF |
Q9NPI8
|
FA complementation group F
|
|
0.46 |
0.535 |
0.731 |
FANCI |
Q9NVI1
|
FA complementation group I
|
|
8.9E-37 |
0.543 |
0.731 |